Expression of the GPI-anchored receptor Prv-1 enhances thrombopoietin and IL-3-induced proliferation in hematopoietic cell lines

Leukemia Research

Volumn 32, Issue 5, 2008, Pages 811-819

  Dillon, Megan ^a,b   Minear, Jennifer ^a,b   Johnson, Jan ^a,b   Lannutti, Brian J ^a,b  

^a PUGET SOUND BLOOD CENTER   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

IL 3; Jak2; Mpl; PRV 1; Thrombopoietin

Indexed keywords

CELL SURFACE RECEPTOR; GLYCOPROTEIN; INTERLEUKIN 3; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN PRV 1; STAT3 PROTEIN; STAT5 PROTEIN; THROMBOPOIETIN; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 40049091584     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.09.018     Document Type: Article

References (53)

1. P.J. Campbell A.R. Green The myeloproliferative disorders N Engl J Med 355 2006 2452
2. J.L. Spivak G. Barosi G. Tognoni Chronic myeloproliferative disorders Hematol Am Soc Hematol Educ Program 2003 200
3. S. Temerinac S. Klippel E. Strunck Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera Blood 95 2000 2569
4. S. Klippel E. Strunck C.E. Busse D. Behringer H.L. Pahl Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera Blood 100 2002 2441
5. L. Teofili M. Martini M. Luongo Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia J Clin Oncol 20 2002 4249
6. S. Klippel E. Strunck S. Temerinac Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis Blood 102 2003 3569
7. I. Stefanova V. Horejsi I.J. Ansotegui W. Knapp H. Stockinger GPI-anchored cell-surface molecules complexed to protein tyrosine kinases Science 254 1991 1016
8. V. Horejsi M. Cebecauer J. Cerny T. Brdicka P. Angelisova K. Drbal Signal transduction in leucocytes via GPI-anchored proteins: an experimental artefact or an aspect of immunoreceptor function? Immunol Lett 63 1998 63
9. I. Dumler A. Weis O.A. Mayboroda The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells J Biol Chem 273 1998 315
10. Y. Koshelnick M. Ehart P. Hufnagl P.C. Heinrich B.R. Binder Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598 J Biol Chem 272 1997 28563
11. J. Bohuslav V. Horejsi C. Hansmann Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes J Exp Med 181 1995 1381
12. F. Chiaradonna L. Fontana C. Iavarone Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence EMBO J 18 1999 3013
13. D.L. Eaton F.J. de Sauvage Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis Exp Hematol 25 1997 1
14. W.S. Alexander A.W. Roberts N.A. Nicola R. Li D. Metcalf Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl Blood 87 1996 2162
15. K. Kaushansky J.G. Drachman The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production Oncogene 21 2002 3359
16. I. Vigon J.P. Mornon L. Cocault Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily Proc Natl Acad Sci USA 89 1992 P5640
17. D.F. Sabath K. Kaushansky V.C. Broudy Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding Blood 94 1999 365
18. K. Kaushansky Hematopoietic growth factors, signaling and the chronic myeloproliferative disorders Cytokine Growth Factor Rev 17 2006 423
19. M. Germeshausen M. Ballmaier K. Welte Implications of mutations in hematopoietic growth factor receptor genes in congenital cytopenias Ann N Y Acad Sci 938 2001 305
20. J. Ding H. Komatsu A. Wakita Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin Blood 103 2004 4198
21. A.D. Pardanani R.L. Levine T. Lasho MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients Blood 108 2006 3472
22. Y. Pikman B.H. Lee T. Mercher MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia PLoS Med 3 2006 e270
23. E.J. Baxter L.M. Scott P.J. Campbell Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders Lancet 365 2005 1054
24. R. Kralovics F. Passamonti A.S. Buser A gain-of-function mutation of JAK2 in myeloproliferative disorders N Engl J Med 352 2005 1779
25. C. James V. Ugo J.P. Le Couedic A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature 434 2005 1144
26. R.L. Levine M. Wadleigh J. Cools Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Cancer Cell 7 2005 387
27. R. Zhao S. Xing Identification of an acquired JAK2 mutation in polycythemia vera J Biol Chem 280 2005 22788
28. D.P. Steensma R.F. McClure J.E. Karp JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained Leukemia 20 2006 971
29. M.J. Percy M.F. McMullin The V617F JAK2 mutation and the myeloproliferative disorders Hematol Oncol 23 2005 91
30. T. Ishii E. Bruno R. Hoffman M. Xu Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera Blood 108 2006 3128
31. A. Gaikwad R. Nussenzveig E. Liu S. Gottshalk K. Chang J.T. Prchal In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele Exp Hematol 35 2007 587
32. P.S. Goerttler C. Steimle E. Marz The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients Blood 106 2005 2862
33. Z. Mnjoyan J. Li V. Afshar-Kharghan Expression of polycythemia rubra vera-1 decreases the dependency of cells on growth factors for proliferation Haematologica 90 2005 405
34. J.G. Drachman K. Kaushansky Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain Proc Natl Acad Sci USA 94 1997 2350
35. C. Lacout D.F. Pisani M. Tulliez F.M. Gachelin W. Vainchenker J.L. Villeval JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis Blood 108 2006 1652
36. M.D. Filippi F. Porteu F.L. Pesteur Requirement for mitogen-activated protein kinase activation in the response of embryonic stem cell-derived hematopoietic cells to thrombopoietin in vitro Blood 99 2002 1174
37. A.L. Gurney S.C. Wong W.J. Henzel F.J. de Sauvage Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation Proc Natl Acad Sci USA 92 1995 5292
38. J.M. Martin K. Gandhi W.R. Jackson E.N. Dessypris Hypersensitivity of polycythemia vera megakaryoctic progenitors to thrombopoetin Blood 88 1996 97a
39. C.H. Dai S.B. Krantz E.N. Dessypris R.T. Means Jr. S.T. Horn H.S. Gilbert Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor Blood 80 1992 891
40. C.H. Dai S.B. Krantz R.T. Means Jr. S.T. Horn H.S. Gilbert Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3 J Clin Invest 87 1991 391
41. N. Meydan T. Grunberger H. Dadi Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor Nature 379 1996 645
42. N.L. Harris E.S. Jaffe J. Diebold The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 Mod Pathol 13 2000 193
43. F. Passamonti D. Pietra E. Rumi PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia Leukemia 19 2005 888
44. E. Liboi M. Carroll A.D. D’Andrea P.B. Mathey Erythropoietin receptor signals both proliferation and erythroid-specific differentiation Proc Natl Acad Sci USA 90 1993 11351
45. R. Palacios M. Steinmetz Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo Cell 41 1985 P727
46. J.G. Drachman P. Rojnuckarin K. Kaushansky Thrombopoietin signal transduction: studies from cell lines and primary cells Methods 17 1999 238
47. U.J. Sachs C.L. Andrei-Selmer A. Maniar The neutrophil specific antigen CD177 is a counter-receptor for endothelial PECAM-1 (CD31) J Biol Chem 282 32 2007 23603
48. T.A. Rege J.S. Hagood Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses Biochim Biophys Acta 1763 2006 991
49. I. Dumler A. Kopmann A. Weis Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells Arterioscler Thromb Vasc Biol 19 1999 290
50. R. Garcia T.L. Bowman G. Niu Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells Oncogene 20 2001 2499
51. O. Levy Y. Granot Arginine-vasopressin activates the JAK-STAT pathway in vascular smooth muscle cells J Biol Chem 281 2006 15597
52. L. Wang T. Kurosaki S.J. Corey Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway Oncogene 26 2006 2851
53. E.P. Reddy A. Korapati P. Chaturvedi S. Rane IL-3 signaling and the role of Src kinases JAKs and STATs: a covert liaison unveiled Oncogene 19 2000 2532